ReNeuron Group (RENE) RNS Announcements

Add to Alert list
Date Time Source Announcement
10 Sep 2009 07:00 AM
RNS
Re Agreement
09 Sep 2009 05:00 PM
RNS
Holding(s) in Company
12 Aug 2009 07:00 AM
RNS
Director/PDMR Shareholding
11 Aug 2009 07:00 AM
RNS
Publication of papers in peer
10 Aug 2009 09:28 AM
RNS
Publication of pre-clinical d
31 Jul 2009 11:21 AM
RNS
2008/09 Annual Report and Acc
30 Jul 2009 10:05 AM
RNS
Regulatory Update
14 Jul 2009 03:48 PM
RNS
Launch of "Life Sciences Blue
08 Jul 2009 09:33 AM
RNS
Publication of data on lead C
30 Jun 2009 07:00 AM
RNS
Final Results
29 Jun 2009 03:44 PM
RNS
Holding(s) in Company
24 Jun 2009 10:30 AM
RNS
Holding(s) in Company
19 Jun 2009 12:17 PM
RNS
Notice of Results
12 Jun 2009 02:56 PM
RNS
Holding(s) in Company
09 Jun 2009 07:00 AM
RNS
Stem cells manufacturing cont
21 May 2009 08:43 AM
RNS
Holding(s) in Company
19 May 2009 01:21 PM
RNS
Holding(s) in Company
19 May 2009 01:18 PM
RNS
Holding(s) in Company
18 May 2009 01:06 PM
RNS
Holding(s) in Company
18 May 2009 07:00 AM
RNS
Final Closing of the Placing
14 May 2009 03:02 PM
RNS
Third Closing Of The Placing
14 May 2009 10:43 AM
RNS
Regulatory update
01 May 2009 07:00 AM
RNS
ReN001 data to be presented a
09 Apr 2009 07:00 AM
RNS
Successful automation of stem
08 Apr 2009 09:51 AM
RNS
Holding(s) in Company
08 Apr 2009 09:43 AM
RNS
Holding(s) in Company
07 Apr 2009 07:00 AM
RNS
Second Closing of the Placing
06 Apr 2009 07:00 AM
RNS
Positive pre-clinical data wi
03 Apr 2009 11:19 AM
RNS
Result of EGM and First Closi
12 Mar 2009 07:00 AM
RNS
Announces Fundraising and Con
24 Feb 2009 04:03 PM
RNS
Holding(s) in Company
26 Jan 2009 07:00 AM
RNS
ReNeuron licenses stem cell l
21 Jan 2009 07:00 AM
RNS
ReNeuron clarifies press comm
19 Jan 2009 07:00 AM
RNS
ReNeuron gains approval to co
28 Nov 2008 07:00 AM
RNS
Interim Results
24 Nov 2008 07:00 AM
RNS
Appointment of NED
14 Nov 2008 03:30 PM
RNS
Research Update
19 Sep 2008 10:46 AM
RNS
Result of AGM
19 Sep 2008 07:00 AM
RNS
AGM Statement
07 Aug 2008 03:33 PM
RNS
Annual Report and Accounts
15 Jul 2008 07:00 AM
RNS
Research Update
24 Jun 2008 07:00 AM
RNS
Final Results
24 Jun 2008 07:00 AM
RNS
Re: Fund Raising
23 Jun 2008 03:38 PM
RNS
Holding(s) in Company
19 Jun 2008 04:33 PM
RNS
Notice of Results
11 Jun 2008 07:00 AM
RNS
Re: ISSCR Conference
29 May 2008 07:00 AM
RNS
Re: Contract
21 May 2008 07:00 AM
RNS
Notice of US Patent Grant
20 May 2008 10:46 AM
RNS
Re: UK Government Vote
23 Apr 2008 07:00 AM
RNS
Research Update

ReNeuron Group plc is a United Kingdom-based clinical-stage stem cell company. The Company is engaged in the development of stem cell therapies targeting areas of unmet or poorly met medical need. It has developed a stem cell-derived, exosome-based, drug delivery platform with customizable cellular targeting capabilities for the delivery of complex drug modalities. Through the generation of several exosome producer cell lines, its CustomEX platform can be optimized for specific tissue targets and payloads, leading to improvements in therapeutic outcome and a reduction in off-target effects. It offers a delivery mechanism for a variety of payloads such as small interfering Ribonucleic Acid (siRNA), messenger RNA (mRNA), proteins, small molecules and genes. Through its conditionally immortalized induced pluripotent stem cell (iPSC) platform, it has the ability to make allogeneic tissue cells of choice and has the potential to produce exosomes with tissue specific targeting ability.

It listed on AIM in 2006 under the ticker RENE.

UK 100

Latest directors dealings